Akbar Ali

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 11

Top Venues

Journal of medicinal chemistry

ACS chemical biology

ACS infectious diseases

Chemical reviews

University of Massachusetts Medical School

University of Karachi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Massachusetts Medical School

United States

Research Associate Professor :: Biochemistry & Molecular Pharmacology

University of Massachusetts Medical School

United States

Research Assistant Professor :: Biochemistry & Molecular Pharmacology

Education History

University of Karachi

Pakistan

PHD :: International Center for Chemical and Biological Sciences

Publications

Richa Arya, Zachary Maben, Digamber Rane, Akbar Ali, Lawrence J Stern
Phenylsulfamoyl Benzoic Acid Inhibitor of ERAP2 with a Novel Mode of Inhibition. ACS chemical biology 17 (7) (2022)
Ashley N Matthew, Florian Leidner, Gordon J Lockbaum, Mina Henes, Jacqueto Zephyr, Shurong Hou, Desaboini Nageswara Rao, Jennifer Timm, Linah N Rusere, Debra A Ragland, Janet L Paulsen, Kristina Prachanronarong, Djade I Soumana, Ellen A Nalivaika, Nese Kurt Yilmaz, Akbar Ali, Celia A Schiffer
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond. Chemical reviews 121 (6) (2021)
Desaboini Nageswara Rao, Jacqueto Zephyr, Mina Henes, Elise T Chan, Ashley N Matthew, Adam K Hedger, Hasahn L Conway, Mohsan Saeed, Alicia Newton, Christos J Petropoulos, Wei Huang, Nese Kurt Yilmaz, Celia A Schiffer, Akbar Ali
Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants. Journal of medicinal chemistry 64 (16) (2021)
Gordon J Lockbaum, Mina Henes, Nathaniel Talledge, Linah N Rusere, Klajdi Kosovrasti, Ellen A Nalivaika, Mohan Somasundaran, Akbar Ali, Louis M Mansky, Nese Kurt Yilmaz, Celia A Schiffer
Inhibiting HTLV-1 Protease: A Viable Antiviral Target. ACS chemical biology 16 (3) (2021)
Jennifer Timm, Klajdi Kosovrasti, Mina Henes, Florian Leidner, Shurong Hou, Akbar Ali, Nese Kurt Yilmaz, Celia A Schiffer
Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir. ACS chemical biology 15 (2) (2020)
Linah N Rusere, Gordon J Lockbaum, Mina Henes, Sook-Kyung Lee, Ean Spielvogel, Desaboini Nageswara Rao, Klajdi Kosovrasti, Ellen A Nalivaika, Ronald Swanstrom, Nese Kurt Yilmaz, Celia A Schiffer, Akbar Ali
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere. Journal of medicinal chemistry 63 (15) (2020)
Linah N Rusere, Gordon J Lockbaum, Sook-Kyung Lee, Mina Henes, Klajdi Kosovrasti, Ean Spielvogel, Ellen A Nalivaika, Ronald Swanstrom, Nese Kurt Yilmaz, Celia A Schiffer, Akbar Ali
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope. Journal of medicinal chemistry 62 (17) (2019)
Zachary Maben, Richa Arya, Digamber Rane, W Frank An, Shailesh Metkar, Marc Hickey, Samantha Bender, Akbar Ali, Tina T Nguyen, Irini Evnouchidou, Roger Schilling, Efstratios Stratikos, Jennifer E Golden, Lawrence J Stern
Discovery of Selective Inhibitors of Endoplasmic Reticulum Aminopeptidase 1. Journal of medicinal chemistry 63 (1) (2019)
Gordon J Lockbaum, Florian Leidner, Linah N Rusere, Mina Henes, Klajdi Kosovrasti, Gily S Nachum, Ellen A Nalivaika, Daniel N A Bolon, Akbar Ali, Nese Kurt Yilmaz, Celia A Schiffer
Correction to Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease. ACS infectious diseases 5 (6) (2019)
Gordon J Lockbaum, Florian Leidner, Linah N Rusere, Mina Henes, Klajdi Kosovrasti, Gily S Nachum, Ellen A Nalivaika, Akbar Ali, Nese Kurt Yilmaz, Celia A Schiffer
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease. ACS infectious diseases 5 (2) (2018)
Ashley N Matthew, Jacqueto Zephyr, Caitlin J Hill, Muhammad Jahangir, Alicia Newton, Christos J Petropoulos, Wei Huang, Nese Kurt-Yilmaz, Celia A Schiffer, Akbar Ali
Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants. Journal of medicinal chemistry 60 (13) (2017)

Akbar Ali.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Akbar Ali